A prospective, multicenter, randomized, open, parallel positive controlled clinical study to evaluate the safety and efficacy of scleral contact lenses for correcting ametropia

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2023
INTERVENTION: Experimental group:Scleral contact lens;Control group:Rigid air permeable contact lens; CONDITION: ametropia PRIMARY OUTCOME: Percentage of patients with corrected visual acuity 5.0 (5 point visual acuity) (minor visual acuity 1.0) in both eyes after 1 week of wearing glasses; SECONDARY OUTCOME: Contact lens corrects vision;Contact lens best corrects vision;Subjective acceptability assessment; INCLUSION CRITERIA: (1) Aged between 18 and 65 (including 18 and 65); (2) Both eyes were within ‐20.00D +20.00D; (3) Able and willing to comply with all treatment and follow‐up; (4) Be able to understand the purpose of the experiment, participate voluntarily and have informed consent signed by the subject himself or his legal guardian.
Epistemonikos ID: 8d5a64e87785c1a4dbd283c9cc0b4c682163f216
First added on: Feb 20, 2024